Get started
Aerovate Therapeutics, Inc.Aerovate Therapeutics, Inc.Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

JBIO chart


Full chart

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as JBIO.

Frequently Asked Questions


The current price of JBIO is 10.14 USD — it hasn't changed in the past 24 hours. Watch Aerovate Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aerovate Therapeutics, Inc. stocks are traded under the ticker JBIO.
JBIO stock has fallen by −2.90% compared to the previous week, the month change is a 5.10% rise, over the last year Aerovate Therapeutics, Inc. has showed a −99.96% decrease.
Yes, you can track Aerovate Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Aerovate Therapeutics, Inc. is going to release the next earnings report on Aug 11, 2025. Keep track of upcoming events with our Earnings Calendar.
JBIO net income for the last quarter is ‪−2.52 M‬ USD, while the quarter before that showed ‪−5.43 M‬ USD of net income which accounts for 53.63% change. Track more Aerovate Therapeutics, Inc. financial stats to get the full picture.
Like other stocks, JBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aerovate Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aerovate Therapeutics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aerovate Therapeutics, Inc. stock shows the strong sell signal. See more of Aerovate Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.